Myris Therapeutics, Inc., 2026-10-14
A new SEC Form D private-offering notice from Sharpsburg, PA, a $4,500,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Developer of polymer based antibody drug conjugates (ADCs) for oncology, using ATRP bottlebrush polymer technology licensed from Carnegie Mellon University research
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- StoryFlight Labs, PBC, 2026-10-21, $1.5M, Pittsburgh, PA
- Immuno Cancer Biotherapeutics, Inc., 2026-10-15, Canton, SD
- Admirra, Inc., 2026-10-16, $1M, Pittsburgh, PA
- Ensho Therapeutics, Inc., 2026-10-15, $15.6M, Woodcliff Lake, NJ
- Lungpacer Medical, Inc., 2026-10-14, $30M, Exton, PA
- Renue Life Sciences, Inc., 2026-10-14, $3M, San Carlos, CA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.